Development of occlusive neointimal lesions in distal pulmonary arteries of endothelin B receptor-deficient rats: a new model of severe pulmonary arterial hypertension.
BACKGROUND
Human pulmonary arterial hypertension (PAH) is characterized by proliferation of vascular smooth muscle and, in its more severe form, by the development of occlusive neointimal lesions. However, few animal models of pulmonary neointimal proliferation exist, thereby limiting a complete understanding of the pathobiology of PAH. Recent studies of the endothelin (ET) system demonstrate that deficiency of the ET(B) receptor predisposes adult rats to acute and chronic hypoxic PAH, yet these animals fail to develop neointimal lesions. Herein, we determined and thereafter showed that exposure of ET(B) receptor-deficient rats to the endothelial toxin monocrotaline (MCT) leads to the development of neointimal lesions that share hallmarks of human PAH.


RESULTS
The pulmonary hemodynamic and morphometric effects of 60 mg/kg MCT in control (MCT(+/+)) and ET(B) receptor-deficient (MCT(sl/sl)) rats at 6 weeks of age were assessed. MCT(sl/sl) rats developed more severe PAH, characterized by elevated pulmonary artery pressure, diminished cardiac output, and right ventricular hypertrophy. In MCT(sl/sl) rats, morphometric evaluation revealed the presence of neointimal lesions within small distal pulmonary arteries, increased medial wall thickness, and decreased arterial-to-alveolar ratio. In keeping with this, barium angiography revealed diminished distal pulmonary vasculature of MCT(sl/sl) rat lungs. Cells within neointimal lesions expressed smooth muscle and endothelial cell markers. Moreover, cells within neointimal lesions exhibited increased levels of proliferation and were located in a tissue microenvironment enriched with vascular endothelial growth factor, tenascin-C, and activated matrix metalloproteinase-9, factors already implicated in human PAH. Finally, assessment of steady state mRNA showed that whereas expression of ET(B) receptors was decreased in MCT(sl/sl) rat lungs, ET(A) receptor expression increased.


CONCLUSIONS
Deficiency of the ET(B) receptor markedly accelerates the progression of PAH in rats treated with MCT and enhances the appearance of cellular and molecular markers associated with the pathobiology of PAH. Collectively, these results suggest an overall antiproliferative effect of the ET(B) receptor in pulmonary vascular homeostasis.
Ivy
D Dunbar
DD
Section of Pediatric Cardiology, University of Colorado School of Medicine and Children's Hospital, Denver 80218, USA. ivy.dunbar@tchden.org
McMurtry
Ivan F
IF
Colvin
Kelley
K
Imamura
Masatoshi
M
Oka
Masahiko
M
Lee
Dong-Seok
DS
Gebb
Sarah
S
Jones
Peter Lloyd
PL
D000818:Animals; D030801:Animals, Genetically Modified; D001157:Arterial Occlusive Diseases / Q000209:etiology*; D049109:Cell Proliferation; D004195:Disease Models, Animal; D006973:Hypertension / Q000209:etiology* / Q000473:pathology; D017380:Hypertrophy, Right Ventricular; D016686:Monocrotaline / Q000009:adverse effects; D009131:Muscle, Smooth, Vascular / Q000473:pathology; D011651:Pulmonary Artery / Q000473:pathology / Q000503:physiopathology; D051381:Rats; D044023:Receptor, Endothelin B / Q000172:deficiency* / Q000502:physiology; D017539:Tunica Intima / Q000473:pathology*
D044023:Receptor, Endothelin B; D016686:Monocrotaline